Arecor Therapeutics (LON:AREC) Hits New 52-Week Low at $86.00

Arecor Therapeutics plc (LON:ARECGet Free Report) reached a new 52-week low on Monday . The company traded as low as GBX 86 ($1.10) and last traded at GBX 91.40 ($1.17), with a volume of 6523 shares traded. The stock had previously closed at GBX 95 ($1.21).

Arecor Therapeutics Trading Down 3.8 %

The firm has a market capitalization of £28.00 million, a price-to-earnings ratio of -326.43 and a beta of -0.15. The company has a fifty day moving average price of GBX 112.65 and a 200-day moving average price of GBX 133.41. The company has a current ratio of 2.17, a quick ratio of 6.24 and a debt-to-equity ratio of 3.55.

About Arecor Therapeutics

(Get Free Report)

Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.

Featured Stories

Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.